510(k) device
Aquadex FlexFlow System 2.0
Chf Solutions, Inc. · Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI, Class II) · First FDA decision Feb 2, 2006, newest Feb 24, 2020Kidney failure and dialysis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
3
Naming "Aquadex FlexFlow"
MAUDE reports
11
Brand "Aquadex FlexFlow", since 2015
PubMed studies
5
Mentioning "Aquadex FlexFlow"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Aquadex FlexFlow System 2.0
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K192756 · Decided Feb 24, 2020 · 147 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Aquadex FlexFlow", any status and sponsor, newest update first.
Nuwellis, Inc.Not on our public-company list
NCT04241718 · 6 participants · Start Dec 19, 2019 · Primary completion Dec 27, 2022
Device: Aquadex FlexFlow System and BVA-100 · For: Acute Decompensated Heart Failure; Fluid Overload
Sites: Naperville, Illinois
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Aquadex FlexFlow", and for the whole product code for context.
This brand
11 reports: 10 malfunction, 0 injury, 1 death
Whole product code KDI
25,025 reports: 21,247 malfunction, 2,993 injury, 752 death
Newest reports for this brand
- AQUADEX FLEXFLOWMalfunction
12982899 · Received Dec 13, 2021 · Event dated Nov 6, 2021
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
Device problem as coded: Reset Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0831-2025 · Started Dec 11, 2024 · Posted by FDA Jan 16, 2025
Reason given: The AquaFlexFlow UF 500 Plus extracorporeal blood circuit used with the Aquadex SmartFlow and FlexFlow Systems may indicate "Ultrafiltrate Weight Mismatch" or Excessive Weight Mismatch Alarms while in use. If not addressed, this failure could result in excess fluid removal from a patient leading to Acute Volume...
Cause as FDA categorized it: Under Investigation by firm · Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
Published research
The most relevant PubMed records for "Aquadex FlexFlow"[tiab]. The summary above synthesizes these.
- Using aquapheresis with continuous hematocrit monitoring to guide ultrafiltration.
Starr MC, Voivodas M, Hains DS · Pediatr Nephrol · 2024Research Support, N.I.H., Extramural
- Outcomes of Ultrafiltration in community-based hospitals.
Chinta VR, Theella NP, Raja JM, et al. · Curr Probl Cardiol · 2024Review
- Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.
Costanzo MR, Negoianu D, Jaski BE, et al. · JACC Heart Fail · 2016Multicenter Study, Randomized Controlled Trial
- Aquapheresis (AQ) in Tandem with Extracorporeal Membrane Oxygenation (ECMO) in Pediatric Patients.
Constantinescu AR, Adler JL, Watkins E, et al. · J Extra Corpor Technol · 2019Case Reports
- Kidney Support in Children using an Ultrafiltration Device: A Multicenter, Retrospective Study.
Menon S, Broderick J, Munshi R, et al. · Clin J Am Soc Nephrol · 2019Multicenter Study
Other devices of this type
Also filed under product code KDI.
- NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)Nxstage Medical, Inc. · 510(k) 2024
- Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc. · 510(k) 2026
- NxStage Cartridge Express with SpeedswapNxstage Medical, Inc. · 510(k) 2019
- Venofer PumpRenal Solutions, Inc. · 510(k) 2012
- multiFiltratePRO SystemFresenius Medical Care Renal Therapies Group, LLC · 510(k) 2026
- Elisio-HNipro Medical Corporation · 510(k) 2026
- FX CorAL 40Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
- FX CorAL 60 (F00012969)Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.